Quote:Clinical trial and late-breaking abstracts (submitted for the January 20 deadline) will be publicly available to download through the conference app at 12 p.m. ET, on Wednesday, February 18, 2026—with the exception of abstracts selected for inclusion in the AACR press program.
B062 Leronlimab is associated with long‑term survival in metastatic TNBC: Enhancing PD-L1 expression, ICI response, and modulates T cell exhaustion.
Posters session B are tomorrow so I wouldn't expect to see the poster itself until after the session.
Peeps here thinking mostly a SABCS redux? Adding: maybe we get a look at the LL#6 and she's doing well? That would be a nice surprise.